Compare

Neuraxis Inc./$NRXS

1D1W1M3M6MYTD1Y5YMAX

About Neuraxis Inc.

Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Ticker
$NRXS
Sector
Health
Primary listing
AMEX
Employees
24

Neuraxis Inc. Metrics

BasicAdvanced
$64M
-
-$1.10
1.38
-

What the Analysts think about Neuraxis Inc.

Analyst ratings (Buy, Hold, Sell) for Neuraxis Inc. stock.
Analyst projections of the future price of Neuraxis Inc. stock.

Neuraxis Inc. Financial Performance

Revenues and expenses
Income statement
AnnuallyQuarterly
2023
YoY growth
Revenue
Net income
Profit margin

Neuraxis Inc. Earnings Performance

Company profitability
Earnings per share
AnnuallyQuarterly
2020
2021
2022
2023
2024
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.